(Date:1/7/2009)...bolsters tie between vitamin D and the brain disea...-- Researchers have identified nine genes that mig...disease. , In addition, they confirmed earlier rep...ene, on chromosome 12, might also increase risk fo...found in people with Alzheimer,s and other dementi...
(Date:1/7/2009)...ly Site to Provide Support and Convenience , , C...nnounced the launch of a new on-line service for p...al skin care information and products. The new Web...vity between patients and their physicians while o... purchase. , , (Photo: http://www.newscom.com/...
(Date:1/7/2009)...) The Greenwall Foundation recently awarded two c...stitute of Bioethics a grant that will allow Drs. ...e ethical challenges health professionals face whi...fe-threatening neuromuscular diseases (LTNMD). , ...f the work of the international HeartSongs Project...
(Date:1/7/2009)... Ore., Jan. 7 Synthetech, Inc.,(OTC Bulletin Boar...provement,Awards for their outstanding accomplishm... & Security (EHS&S) Planning and Operation...rds are presented by the Synthetic Organic,Chemica...by ChemStewards,SOCMA,s EHS&S improvement init...
Breaking Medicine News(10 mins):Health News:9 Genes Are Linked to Alzheimer's 2Health News:SkinMedica Launches On-Line Service for Physician Partners 2Health News:Study to explore ethical challenges health professionals face while caring for children with LTNMDs 2Health News:Study to explore ethical challenges health professionals face while caring for children with LTNMDs 3Health News:Synthetech Earns National Recognition for Performance Improvement Program 2Health News:Synthetech Earns National Recognition for Performance Improvement Program 3(Date:1/6/2009)...ewswire-FirstCall/ -- , - Early Renewal of ...ecember 2011 , - Expansion of the Scope of ...n Ophthalmology , - Revised Commercial Term... to a Third Party , ExonHit Therapeutics ...,of its existing drug discovery collaboration wit...
(Date:1/3/2009)...ONT, Ill., Jan. 2 Magne...y providing an increasing number of clinical benef...ding to an article in the January 2009 issue of th...urgeons ( http://www.jaaos.org/ ). It is predicte...hnical developments will allow MRI to provide even...
(Date:12/27/2008)...RNewswire/ -- According to the latest,science, re...odest doses of,resveratrol plus an array of antio...glasses of aged, red wine, rather than resveratrol...cgi-bin/prnh/20080603/LATU039 ) , The most...ils to prolong,the life of laboratory mice. In f...
(Date:12/17/2008)...Kind; 80 Percent of Trauma Patient,s Face Transpla... A multi-disciplinary team of doctors and surgeons...near-total face transplant in the United States....n the past two weeks, surgeons transplanted 80 per...trauma -- essentially replacing her entire face, e...
Breaking Medicine Technology:ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4MRI Emerges As Vital Resource in Treatment of Back Pain 2MRI Emerges As Vital Resource in Treatment of Back Pain 3Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 3Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant 2Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant 3U S Workers Taking Steps to Lower Medical Costs Watson Wyatt Survey Finds 31835 1U S Workers Taking Steps to Lower Medical Costs Watson Wyatt Survey Finds 31835 2U S Workers Taking Steps to Lower Medical Costs Watson Wyatt Survey Finds 31835 3According to a New Government Survey 38 Percent of Adults and 12 Percent of Children Use Complementary and Alternative Medicine 31832 1According to a New Government Survey 38 Percent of Adults and 12 Percent of Children Use Complementary and Alternative Medicine 31832 2According to a New Government Survey 38 Percent of Adults and 12 Percent of Children Use Complementary and Alternative Medicine 31832 3According to a New Government Survey 38 Percent of Adults and 12 Percent of Children Use Complementary and Alternative Medicine 31832 4According to a New Government Survey 38 Percent of Adults and 12 Percent of Children Use Complementary and Alternative Medicine 31832 5Hoana Medical to Present at the National Forum on Quality Improvement in Health Care 31829 1Hoana Medical to Present at the National Forum on Quality Improvement in Health Care 31829 2Hoana Medical to Present at the National Forum on Quality Improvement in Health Care 31829 3Hoana Medical to Present at the National Forum on Quality Improvement in Health Care 31829 438 25 of U S Adults Use Alternative Treatments 31826 138 25 of U S Adults Use Alternative Treatments 31826 238 25 of U S Adults Use Alternative Treatments 31826 3...ares favorably with,the activity of mTOR inhibitor...tCall/ - AEterna,Zentaris Inc. , a global biopharm... oncology, today announced that its partner,Keryx...hase 1 and,Phase 2 results for perifosine, an oral...d, for the treatment of patients with,advanced sar...
...stCall/ -- Kosan,Biosciences Incorporated presente...KOS-1584/R1645, an epothilone under,co-development...vity and tolerability in patients with solid tumor...ts (13 of 41,evaluable) including activity in pati...ostate, head and neck and other cancers. Common,to...
Other Medicine Technology:AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 2AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 3AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 4Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 2Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 3Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 4Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 5LigaSure system generator, bipolar only. Designed to permanently seal vessels and tissue bundles.
Sabre 180 is a powerful niche generator.
Sabre 180 is a powerful niche generator.
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator.
Medicine Products: